ImmunityBio

IBRX

Börsenwert 8,71 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Wildcat Capital Management New York	25,7 Mio. $	-4,73 Mio. $	-1.093.956	-24 %
2	2 BlackRock New York	20,9 Mio. $	+2,96 Mio. $	+686.208	+33 %
3	3 Capital Research Global Investors Los Angeles, California	20,2 Mio. $	–	–	–
4	4 Fidelity Investments Boston, Massachusetts	13,2 Mio. $	-46.224 $	-10.700	-0,6 %
5	5 Vanguard Group Malvern, Pennsylvania	11,3 Mio. $	-2,57 Mio. $	-595.017	-29 %
6	6 State Street Boston, Massachusetts	2,59 Mio. $	+509.527 $	+117.946	+53 %
7	7 Northern Trust Chicago, Illinois	2,31 Mio. $	+530.954 $	+122.906	+68 %
8	8 Geode Capital Management Boston, Massachusetts	2,21 Mio. $	+150.345 $	+34.802	+14 %
9	AG 9 Artal Group Luxembourg	1,71 Mio. $	–	–	–
10	10 Vident Investment Advisory Alpharetta, Georgia	1,38 Mio. $	+183.432 $	+42.461	+31 %
11	11 JP Morgan Chase New York	1,17 Mio. $	+120.848 $	+27.974	+22 %
12	12 Bank of New York Mellon New York	928.000 $	+172.035 $	+39.823	+48 %
13	13 Charles Schwab San Francisco, California	799.000 $	+229.539 $	+53.134	+102 %
14	14 Renaissance Technologies New York	679.000 $	-1,71 Mio. $	-396.700	-82 %
15	15 TIAA CREF Investment Management New York	618.000 $	+128.321 $	+29.704	+57 %
16	16 ALPS Advisors Denver, Colorado	563.000 $	+320.354 $	+74.156	Neu
17	17 Teachers Advisors New York	425.000 $	+66.757 $	+15.453	+38 %
18	18 AllianceBernstein Nashville, Tennessee	417.000 $	+91.584 $	+21.200	+63 %
19	19 California State Teachers Retirement System (CalSTRS) West Sacramento, California	411.000 $	+85.968 $	+19.900	+58 %
20	20 Goldman Sachs New York	396.000 $	-64.403 $	-14.908	-22 %
21	21 Balyasny Asset Management Chicago, Illinois	380.000 $	+216.000 $	+50.000	Neu
22	22 DekaBank Deutsche Girozentrale Frankfurt, Germany	365.000 $	+209.088 $	+48.400	Neu
23	23 ProShare Advisors Bethesda, Maryland	341.000 $	-4.389 $	-1.016	-2 %
24	24 Deutsche Bank Frankfurt Am Main Ge, Germany	294.000 $	-480.648 $	-111.261	-74 %
25	25 Millennium Management New York	288.000 $	-5.080 $	-1.176	-3 %

ImmunityBio IBRX Börsenwert 8,71 Mrd. $

ImmunityBio

IBRX

Börsenwert 8,71 Mrd. $